International Journal of Medicine in Developing Countries

Review Article

Previous Article Next Article

IJMDC. 2023; 7(6): 937-943

DOI: 10.24911/IJMDC.51-1673177339

Utilization of antiviral for HIV prevention

Authors: Abdulaziz Alhazmi.

ABSTRACT

Acquired immunodeficiency disease syndrome (AIDS) and AIDS-related illnesses continue to cause a public and economic burden on any given community. Different preventive strategies have been reported, which vary in their effectiveness and safety to limit human immunodeficiency virus (HIV) transmission, the causative virus of AIDS. Antiretroviral therapy (ART) is the main agent used for HIV treatment, and it has been used as a prevention method, or prophylaxis, to prevent HIV transmission. This review was conducted to evaluate clinical trials, and updated recommendations for preventing HIV infection for individuals at risk using ART. We reviewed the literature, and six studies responded to our inclusion criteria. Most of the recent studies that used ART seemed effective in preventing HIV infection among seronegative individuals. Further studies on a larger and different population are recommended to ensure the best preventive methods against HIV.

Keywords:
HIV, AIDS, PREP, France, Europe, WHO


View PDF
Open access Creative Commons License
';
Utilization of antiviral for HIV prevention


Authors
Abdulaziz Alhazmi
Faculty of Medicine Jazan University, Jazan, Saudi Arabia.
PubMed articlesGoogle scholar articles


Correspondence to:
. Faculty of Medicine Jazan University, Jazan, Saudi Arabia; Abalhazmi@jazanu.edu.sa

Publication history
Received 08 Jan 2023
Accepted 12 Jan 2023
Published online 13 Jan 2023
Published in print 13 Mar 2023

How to cite this article?

Export to EndNote Export to refMan

Pubmed Style

Abdulaziz Alhazmi. Utilization of antiviral for HIV prevention. IJMDC. 2023; 7(6): 937-943. doi:10.24911/IJMDC.51-1673177339


Web Style

Abdulaziz Alhazmi. Utilization of antiviral for HIV prevention. https://www.ijmdc.com/?mno=137726 [Access: May 28, 2023]. doi:10.24911/IJMDC.51-1673177339


AMA (American Medical Association) Style

Abdulaziz Alhazmi. Utilization of antiviral for HIV prevention. IJMDC. 2023; 7(6): 937-943. doi:10.24911/IJMDC.51-1673177339


Vancouver/ICMJE Style

Abdulaziz Alhazmi. Utilization of antiviral for HIV prevention. IJMDC. (2023), [cited May 28, 2023]; 7(6): 937-943. doi:10.24911/IJMDC.51-1673177339


Harvard Style

Abdulaziz Alhazmi (2023) Utilization of antiviral for HIV prevention. IJMDC, 7 (6), 937-943. doi:10.24911/IJMDC.51-1673177339


Turabian Style

Abdulaziz Alhazmi. 2023. Utilization of antiviral for HIV prevention. International Journal of Medicine in Developing Countries, 7 (6), 937-943. doi:10.24911/IJMDC.51-1673177339


Chicago Style

Abdulaziz Alhazmi. "Utilization of antiviral for HIV prevention." International Journal of Medicine in Developing Countries 7 (2023), 937-943. doi:10.24911/IJMDC.51-1673177339


MLA (The Modern Language Association) Style

Abdulaziz Alhazmi. "Utilization of antiviral for HIV prevention." International Journal of Medicine in Developing Countries 7.6 (2023), 937-943. Print. doi:10.24911/IJMDC.51-1673177339


APA (American Psychological Association) Style

Abdulaziz Alhazmi (2023) Utilization of antiviral for HIV prevention. International Journal of Medicine in Developing Countries, 7 (6), 937-943. doi:10.24911/IJMDC.51-1673177339


Share this article

Click the icon of the social media platform on which you would like to share this article.

Article Statistics

Request permissions

If you wish to reuse any part or all of this article please contact the copyright holder, contact@ijmdc.com.

Copyright ©2023 Discover STM Publishing. All Rights Reserved.